The Skin Health Institute is excited to bring you a wonderful addition to our Online Biologics Education Portal: the ‘Psoriasis: Back to Basics’ program.
This 6-module curriculum is a highly practical resource for clinicians at the frontline of one of the most challenging dermatological disorders. Led by Associate Professor Peter Foley from the Skin Health Institute, the program provides comprehensive training on psoriasis aetiology, presentation, assessment and treatment, with a focus on up-to-date clinical evidence and prescribing strategies for the currently available biologic therapies.
Each module only takes 30-60 minutes to complete and certificates are issued upon completion of the course.
AFTER COMPLETING THIS PROGRAM, PARTICIPANTS WILL BE ABLE TO:
- DESCRIBE THE AETIOLOGY, FEATURES, RISK FACTORS AND TRIGGERS FOR THE DIFFERENT TYPES OF PSORIASIS
- EVALUATE THE CLINICAL SEVERITY OF PSORIASIS AND ITS EFFECTS ON QUALITY OF LIFE AND PSYCHOSOCIAL HEALTH
- DESCRIBE THE AVAILABLE BIOLOGIC THERAPIES FOR PSORIASIS, INCLUDING MECHANISMS OF ACTION AND EVIDENCE FOR EFFICACY AND SAFETY
- UNDERSTAND THE RISK OF MALIGNANCY IN THE PSORIATIC PATIENT AND RECOMMENDATIONS FOR MANAGING THESE PATIENTS
- SELECT AND SWITCH BIOLOGIC TREATMENTS FOR PSORIASIS BASED ON PATIENT FACTORS, EFFICACY AND SAFETY, INDICATIONS AND GUIDELINE RECOMMENDATIONS
- UNDERSTAND THE EVIDENCE FOR THE SAFETY OF BIOLOGIC THERAPY IN PREGNANT AND LACTATING WOMEN WITH PSORIASIS
- UNDERSTAND THE CRITERIA AND APPLICATION PROCESSES FOR INITIAL AND CONTINUING PBS SUBSIDISED BIOLOGIC THERAPY FOR SEVERE CHRONIC PLAQUE PSORIASIS
- Module 1 – Overview and Comorbidities
Module 1 provides a comprehensive psoriasis overview by Dr Aaron Robinson, providing you up an up-to-date summary on psoriasis epidemiology, exploring the triggers related to the development of psoriasis and explaining the differential characteristics associated with the diverse presentations of psoriasis. Dr Ben Daniels, then reviews the important co-morbidities associated with Psoriasis, providing a thorough review of the association of psoriasis with known comorbidities and how these should be monitored in patients with psoriasis.
- Module 2 – Pregnancy, Biologics and Malignancy
Module 2 has Dr Katherine Armour providing you with the most recent updates and summaries on understanding the background considerations and risks for patients with psoriasis during pregnancy and what the current recommendations are for the benefits and risks associated with psoriasis treatments. Dr Diana Rubel provides a thorough review of risks of malignancy that is inherent with a psoriasis diagnosis and considerations of the mechanistic risks and real world data for both non-biologic and biologic treatment benefits and risks.
- Module 3 – Assessment Tools and Quality of Life
PASI assessment is a requirement for biologic eligibility on the PBS. Dr Rebecca Nguyen provides an excellent review of the PASI scoring system with a case study to demonstrate how to use this assessment tool effectively. A/Prof Chris Baker then reviews the importance of quality of life considerations in psoriasis patients and explains the relationship between PASI scores and QoL measures. It is not always as clear cut as you may imagine. He reviews the current HR QoL tools available to dermatologists which provide generic or specific patient information, which can be very useful for management decisions.
- Module 4 – Psoriasis: Biologic Agents in Dermatology
A/Prof Peter Foley starts off module 4 with a discussion on biologic agents that are currently available for the management of chronic plaque psoriasis. He starts with an overview of biologic therapies, and then continues to talk about tumour necrosis factor (TNF) antagonists.
Dr Sarah Hannam then takes over discussing the interleukin 17 (IL 17) antagonists, before Dr Rebecca Nguyen completes this module by providing an overview of the interleukin 23 (IL 23) antagonists.
- Module 5 – Selecting Biologics and Switching
In this module, A/Prof Peter Foley first discusses how to switch from one biologic to another. He starts with a discussion on why switching would be a consideration and evaluates the safety concerns. Advice on how to switch between various biologics is then presented, before he moves on to expertly give an insight into the thought processes involved and factors to be considered when choosing a biologic treatment.
- Module 6 – Psoriasis: PBS Requirements for Adults with Severe Chronic Plaque Psoriasis
In module 6, clinical nurse consultant for dermatology biologics Sue Anderson discusses all things PBS for adults with severe chronic plaque psoriasis. She covers initial authority applications, continuation authority applications, change -, break – or recommencement applications and how to lodge.
She starts off with the criteria for initial PBS subsidized biologic therapy, including pre-biologic considerations, recommended screening pathology and PASI assessments. She provides a step-by-step guide on PB112 form completion and lodgement.Click to access course
This program also features the following Skin Health Institute consultants:
- Dr Aaron Robinson, BBiotech (Hons), MBBS, PhD, FACD
- Dr Katherine Armour, MBCHB (OTAGO), FACD
- Dr Diana Rubel, MBBS, DIP PAEDS, MMED, FACDhttps://www.skinhealthinstitute.org.au/events/48/psoriasis-qa/#aaron
- Dr Ben Daniel, MBBS, MMED (CLIN EPI) (HONS), BA, BCOM, FACD
- A/Prof Chris Baker, MBBS FACD
- Dr Sarah Hannam, MBBS(Hons), FACD
- Dr Rebecca Nguyen, MBBS(Hons), FACD
- Sue Anderson, RN
Q&A workshop videos
28 September – Psoriasis: Back to Basics Program Q&A Workshop 1 – Modules 1 & 3
27 October – Psoriasis: Back to Basics Program Q&A Workshop 2 – Modules 4&5
15 November – Psoriasis: Back to Basics Program Q&A Workshop 3 – Modules 2&6